Latest News

NOX closes $4m capital raising for US subsidiary Nyrada Inc
NOX receives FY17 R&D Tax Rebate
EOY Guidance on 2018 NOX66 Clinical Development Strategy
NOX Open Briefing Corporate Presentation
Compassionate use of NOX66 in Patients
AGM Presentations
Promising Interim Clinical Data for NOX66
Results of Meeting
EGM Presentations
UNSW collaboration confirms drug designed for stroke victims